Geode Capital Management LLC grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 0.3% during the fourth quarter, HoldingsChannel reports. The firm owned 2,201,232 shares of the company’s stock after buying an additional 5,671 shares during the period. Geode Capital Management LLC’s holdings in HealthEquity were worth $201,685,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Capricorn Fund Managers Ltd acquired a new position in shares of HealthEquity during the fourth quarter worth about $6,926,000. 12th Street Asset Management Company LLC lifted its stake in shares of HealthEquity by 114.4% in the third quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after acquiring an additional 145,151 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of HealthEquity by 45.5% in the third quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after acquiring an additional 48,621 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of HealthEquity by 21.3% in the third quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock worth $33,108,000 after acquiring an additional 61,317 shares in the last quarter. Finally, King Luther Capital Management Corp lifted its stake in shares of HealthEquity by 60.6% in the third quarter. King Luther Capital Management Corp now owns 80,584 shares of the company’s stock worth $7,637,000 after acquiring an additional 30,394 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. Royal Bank Of Canada boosted their price target on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Friday, May 29th. Barclays cut their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. Barrington Research reiterated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. Finally, Jefferies Financial Group set a $108.00 price objective on HealthEquity in a research note on Thursday, February 19th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $111.53.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock worth $1,193,000 over the last quarter. 1.60% of the stock is owned by corporate insiders.
HealthEquity Trading Down 2.5%
Shares of NASDAQ HQY opened at $88.34 on Wednesday. The stock’s 50 day moving average price is $83.63 and its two-hundred day moving average price is $86.61. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $116.65. The stock has a market capitalization of $7.39 billion, a P/E ratio of 33.09, a PEG ratio of 1.55 and a beta of 0.21. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million for the quarter, compared to analysts’ expectations of $352.02 million. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
